Guardian Pharmacy Services, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Guardian Pharmacy Services, Inc. announced robust financial results for the second quarter of 2026, showcasing significant revenue and net income increases.
NYSE
Guardian Pharmacy Services reports a 2.2% revenue increase in Q1 2026, driven by acquisitions, despite organic revenue decline due to IRA pricing.
NYSE
Guardian Pharmacy Services, Inc. reported a significant turnaround in profitability and robust revenue growth for the third quarter and first nine months of 2025, driven by organic expansion and strategic acquisitions.
NYSE
Guardian Pharmacy Services, Inc. reported significant revenue and Adjusted EBITDA growth for Q2 and H1 2025, driven by organic expansion and strategic acquisitions, despite a decline in GAAP net income due to post-IPO accounting changes.
NYSE
Guardian Pharmacy Services reports a 19.6% increase in revenue for Q1 2025, driven by both acquisitions and organic growth, marking its first quarter as a public company.
NYSE
Guardian Pharmacy Services reports its Q3 2024 results, which include a significant net loss due to costs associated with its recent IPO and corporate reorganization, despite revenue growth.